CRIS Current Research Information System

TAGLIERI, NEVIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.790
AS - Asia 5.565
EU - Europa 5.412
AF - Africa 594
SA - Sud America 345
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
AN - Antartide 1
Totale 19.718
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.720
SG - Singapore 1.737
CN - Cina 1.379
VN - Vietnam 1.353
GB - Regno Unito 1.299
IT - Italia 823
DE - Germania 813
SE - Svezia 717
HK - Hong Kong 452
IN - India 308
RU - Federazione Russa 291
BR - Brasile 251
FR - Francia 248
IE - Irlanda 247
UA - Ucraina 229
NL - Olanda 226
CI - Costa d'Avorio 166
TG - Togo 129
ZA - Sudafrica 106
SC - Seychelles 104
BG - Bulgaria 101
FI - Finlandia 100
EE - Estonia 93
JO - Giordania 88
NG - Nigeria 77
CH - Svizzera 62
JP - Giappone 59
KR - Corea 57
CA - Canada 49
BE - Belgio 45
AR - Argentina 42
IR - Iran 36
PL - Polonia 26
AT - Austria 22
ID - Indonesia 21
EC - Ecuador 19
MX - Messico 15
LT - Lituania 12
TR - Turchia 12
ES - Italia 11
UZ - Uzbekistan 10
CL - Cile 9
CO - Colombia 9
RO - Romania 9
BD - Bangladesh 8
HR - Croazia 6
IQ - Iraq 6
AU - Australia 5
GR - Grecia 5
LB - Libano 5
PY - Paraguay 5
VE - Venezuela 5
CZ - Repubblica Ceca 4
EG - Egitto 4
PK - Pakistan 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
MK - Macedonia 3
MN - Mongolia 3
OM - Oman 3
PE - Perù 3
SA - Arabia Saudita 3
SI - Slovenia 3
TW - Taiwan 3
AL - Albania 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
NZ - Nuova Zelanda 2
PH - Filippine 2
TH - Thailandia 2
AM - Armenia 1
AQ - Antartide 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
CV - Capo Verde 1
DO - Repubblica Dominicana 1
EU - Europa 1
GE - Georgia 1
GI - Gibilterra 1
GT - Guatemala 1
HN - Honduras 1
HT - Haiti 1
HU - Ungheria 1
IS - Islanda 1
JM - Giamaica 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
NE - Niger 1
NO - Norvegia 1
QA - Qatar 1
RS - Serbia 1
SN - Senegal 1
SO - Somalia 1
Totale 19.715
Salva come PNG Salva come JPEG
Città #
Singapore 1.124
Southend 1.113
Ashburn 947
Fairfield 748
Chandler 706
Hong Kong 451
Santa Clara 400
Woodbridge 362
Houston 353
Wilmington 348
Seattle 327
Ann Arbor 299
Ho Chi Minh City 294
Princeton 285
Cambridge 258
Dublin 245
Beijing 237
Hanoi 215
Boardman 206
Dong Ket 203
Abidjan 166
Hefei 157
Jacksonville 131
Lomé 129
Bologna 128
New York 128
Westminster 116
Bremen 108
Nanjing 108
Padova 108
Turin 103
Los Angeles 100
Berlin 98
Sofia 98
Amman 88
Abeokuta 77
Milan 72
Munich 67
Dallas 63
Buffalo 60
Redondo Beach 58
Saint Petersburg 56
Frankfurt am Main 55
Helsinki 55
San Diego 53
Bern 52
Tokyo 52
Seoul 51
Changsha 46
Brussels 44
Shenyang 43
Jinan 42
Medford 40
Turku 40
Nanchang 39
Dearborn 38
Hebei 35
Guangzhou 31
Yubileyny 30
Jiaxing 28
Da Nang 27
Falkenstein 27
Mülheim 27
São Paulo 27
London 26
Pune 26
Toronto 25
Biên Hòa 24
Shanghai 24
Zhengzhou 24
Haiphong 23
Tianjin 23
Florence 22
Norwalk 22
Rome 22
Olalla 21
Quận Bình Thạnh 21
Mountain View 20
Düsseldorf 19
Paris 19
Phoenix 19
Redmond 19
Falls Church 18
Lanzhou 18
Des Moines 17
Taizhou 17
The Dalles 17
Washington 17
Chicago 16
Ha Long 16
Taiyuan 16
Verona 16
Kuban 15
Mahé 15
Shenzhen 15
Nuremberg 14
Warsaw 14
Can Tho 13
Haikou 13
Hangzhou 13
Totale 12.901
Salva come PNG Salva come JPEG
Nome #
Cystatin C and Cardiovascular Risk 343
The role of the vascular surgeon in transcatheter aortic valve implantation 230
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 229
Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI 224
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. 216
Detection of Tissue Factor Antigen and Coagulation Activity in Coronary Artery Thrombi Isolated from Patients with ST-Segment Elevation Acute Myocardial Infarction 213
Incidence and Outcome of High On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] Study) 210
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 198
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 198
Cognitive functions: Evaluation and changes after transcatheter aortic valve implantation in elderly patients 196
Carbon dioxide coronary angiography: A mechanical feasibility study with a cardiovascular simulator 196
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 195
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 195
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 192
Long-term clinical and angiographic outcome of patients with occlusive in-stent restenosis treated with (32P) beta-brachytherapy. 189
[Cystatin C and cardiovascular risk. 185
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 183
32P brachytherapy in the treatment of complex Cypher in-stent restenosis. 181
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 181
Troponin T elevation in acute aortic syndromes: Frequency and impact on diagnostic delay and misdiagnosis 177
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 177
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 176
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 176
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year clinical outcome 175
Prognostic Significance of Baseline White Blood Cell Count in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome. 174
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 172
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 170
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 166
Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation 166
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 163
Cistatina C and rischio cardiovascolare 162
Prognostic significance of shockable and non-shockable cardiac arrest in ST-segment elevation myocardial infarction patients undergoing primary angioplasty 162
Inferior Q waves in apparently healthy subjects: Should we take a deep breath? An electrocardiographic, echocardiographic and cardiac magnetic resonance study 161
The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. 157
Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention 157
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 156
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 156
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 155
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 155
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 153
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 152
Cystatin C and cardiovascular risk. 151
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 151
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 151
Secondary prevention medical therapy and outcomes in patients with myocardial infarction with non-obstructive coronary artery disease 151
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 150
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 150
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 149
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 149
Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). 148
Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study 148
Mid-term and long-term mortality associated with heart failure in patients hospitalized for acute coronary syndromes 146
Detection of tissue factor antigen and coagulation activity in coronary artery thrombi isolated from patients with ST-segment elevation acute myocardial infarction 146
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 146
What is the acceptable rate of false positives for STEMI within a primary PCI network? Insights from a metropolitan system with direct ambulance-based access. 146
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 145
Residual aortic regurgitation is a major determinant of late mortality after transcatheter aortic valve implantation 144
Peripheral arterial disease and long-term mortality following acute coronary syndromes: insights from a large registry of unselected patients 143
Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials 143
Long-term prognostic role of cerebrovascular disease and peripheral arterial disease across the spectrum of acute coronary syndromes 143
Movement compensation during carbon dioxide coronary angiography: In-vitro validation 143
Circulating miR-184 is a potential predictive biomarker of cardiac damage in Anderson–Fabry disease 143
Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. 142
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 142
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 142
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 142
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 141
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 141
Left Main Coronary Artery Compression in Patients With Pulmonary Arterial Hypertension and Angina 141
Clinical impact of direct referral to primary percutaneous coronary intervention following pre-hospital diagnosis of ST-elevation myocardial infarction. 140
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 138
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 135
Randomized comparison between tirofiban and abcximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abcximab (FATA) in ST-elevation myocardial infarction trial 134
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 134
How should i treat an unexpected deadlock at the time of transcatheter aortic valve prosthesis implantation? 134
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 134
Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention 133
A rescue transcatheter solution for early sutureless basal ring infolding 132
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 132
EVEROLIMUS REDUCES CAV PROGRESSION AS COMPARED WITH AZATHIOPRINE AND MYCOPHENOLATE: A LONGITUDINAL IVUS- BASED STUDY 132
Left ventricular recovery after ST-elevation myocardial infarction in patients treated with primary coronary angioplasty and abciximab or tirofiban 131
Impact of gene polymorphisms, platelet reactivity, and the SYNTAX score on 1-year clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention: The GEPRESS study 131
PREDICTING CARDIOVASCULAR OUTCOMES LONG-TERM AFTER HEART TRANSPLANT BY LATE CHANGES IN MAXIMAL INTIMAL THICKNESS: BEYOND THE HYSTORICAL 1-YEAR LIMIT 131
Standard ECG to predict culprit left main disease in unselected patients with non ST-segment elevation acute coronary syndrome 131
Repeated Aortic Balloon Valvuloplasty in Elderly Patients With Aortic Stenosis Who Are Not Candidates for Definitive Treatment 128
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 126
Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease 126
Effect of cerebrovascular disease on long-term outcome of patients with acute coronary syndromes: findings from a large cohort of unselected patients 125
Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry 125
Predictors of beta-brachytherapy failure in patients with high-risk in-stent restenosis 123
One-year outcome of patients eligible to transcatheter aortic valve implantation according to actual treatment 123
Risk of stroke with percutaneous coronary intervention compared with on-pump and off-pump coronary artery bypass graft surgery: Evidence from a comprehensive network meta-analysis. 122
Acute hand ischemia after radial intervention in patient with CREST-associated pulmonary hypertension: successful treatment with manual thromboaspiration. 122
Risk of stroke in patients with high on clopidrogel platelet reactivity to ADP after percutaneous coronary intervention: systematic review and meta-analysis 122
Predictors of 32P h brachytherapy failure in patients with high-risk in-stent restenosis 122
Occurrence of major bleeding during long-term follow up of unselected patients with STE vs NSTE Acute Coronary Syndromes 121
Prognostic significance of mean platelet volume on admission in unselected cohort of patients with non ST-segment elevation acute coronary syndrome 120
Influence of C-reactive protein on the effectiveness of IIb/IIIa agents in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 119
Multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in Non-ST-Segment elevation acute coronary syndrome 119
Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with tirofiban or Abciximab [FATA] trial) 118
Totale 15.612
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.208
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.026 0 0 0 0 0 59 25 77 179 77 63 546
2021/20222.491 200 120 145 222 204 120 49 193 85 188 518 447
2022/20233.267 268 458 176 450 268 267 77 179 593 83 281 167
2023/2024985 70 125 49 117 86 309 35 54 21 60 30 29
2024/20253.480 196 484 303 280 532 188 169 103 56 319 130 720
2025/20264.046 1.060 687 601 604 847 247 0 0 0 0 0 0
Totale 20.169